Our patient was referred for staging 18F-FDG PET/MRI of her known locally advanced nasopharyngeal squamous cell carcinoma. Overall, her imaging findings were in keeping with the patient’s ...

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and CD70 ...

The common malignant lesions in this region include esthesioneuroblastoma, nasopharyngeal carcinoma, neuroendocrine carcinoma, rhabdomyosarcoma, lymphoepithelioma, lymphoma, melanoma and poorly ...

We previously reported that magnetic resonance imaging evidence of cranial nerve invasion was an unfavourable prognostic factor in nasopharyngeal carcinoma. However, the prognostic value of this ...

Nasopharyngeal carcinoma of the undifferentiated histologic subtype is endemic and prevalent in southeast Asia. The dramatic improvement of treatment outcomes and overall prognosis during the past few ...

Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma. A. D. King and others. Annals of Oncology, 2019. Volume 30, Pahes 977–982. The Evolving ...

Nasopharyngeal cancer may cause signs like: Swelling or lump in your neck that doesn’t go away; ... Imaging tests. Scans of your neck can show if you have cancer and if it’s spread.

Penpulimab-kcqx, a humanized immunoglobulin G1 monoclonal antibody, blocks the interaction between the programmed death 1 receptor on T-cells and programmed death ligand 1 and 2 on tumor cells.

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and CD70 ...

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and CD70 ...